Gastrointestinal Endoscopy

Osaka Metropolitan University researchers conducted a large-scale clinical study to identify long-term rebleeding rates and predictors of rebleeding after capsule endoscopy (CE) in patients with obscure gastrointestinal bleeding (OGIB). The results revealed that the overall cumulative rebleeding rate in the five years after CE was as high as 41.7%, and they also suggested the need for particularly careful follow-up in patients with liver cirrhosis, those taking anticoagulants, or those with previous massive bleeding. The study offers an important finding in considering the long-term follow-up regarding OGIB, and might contribute to future clinical guidelines for OGIB treatment.